Including patients with concomitant gastrointestinal and liver involvement at GVHD onset, REG3α emerged as a stronger diagnostic biomarker for liver gastrointestinal GVHD compared to HGF and Keratin 18 (KRT18). This evidence concerns the gene HGF and graft versus host disease.